Related Experiment Video
Updated: Jun 26, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Chimeric Pathogen-Associated Molecular Patterns (PAMPs) as Vaccine Adjuvants
Bethany M Potter1,2, Anya F Weth1, Emma M Dangerfield1
1School of Chemical and Physical Sciences, Victoria University of Wellington, Wellington P.O. Box 600, New Zealand.
Covalently linking pathogen-associated molecular patterns (PAMPs) creates "chimeric" molecules that enhance immune cell activation and adjuvant activity. This strategy shows promise for infectious disease, allergy, and cancer immunotherapy vaccines.
Area of Science:
- Immunology
- Vaccinology
- Molecular Biology
Background:
- Pathogen-associated molecular patterns (PAMPs) signal through pathogen recognition receptors (PRRs) on innate immune cells, a common adjuvant strategy.
- The impact of covalently linking different PAMPs on immune responses is less understood.
Purpose of the Study:
- To review the effects of PAMP linkage on innate and adaptive immune responses.
- To explore the potential of PAMP conjugates as vaccine adjuvants.
Main Methods:
- Literature review of studies on PAMP linkage and immune responses.
- Analysis of immune cell synergies and adjuvant activity of PAMP conjugates.
Main Results:
- Covalently linked PAMPs (chimeric PAMPs) often induce synergistic immune cell activation compared to unlinked PAMPs.
- PAMP conjugates demonstrate significant adjuvant activity in infectious disease, allergy, and cancer immunotherapy models.
- Potential mechanisms include enhanced PRR signaling crosstalk, particulate formation, improved endosomal targeting, and reduced toxicity.
Conclusions:
- PAMP conjugates represent a promising platform for developing advanced vaccine adjuvants.
- Further research is needed to understand linker chemistry, PRR signaling combinations, and immune response skewing.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
Related Concept Videos
Vaccines
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Vaccinations